Results 111 to 120 of about 19,854 (197)

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia. [PDF]

J Cell Mol Med
Woźniak-Szczepocka A, Pawlos A, Gorzelak-Pabiś P, Broncel M, Bukowska B, Woźniak E.   +5 more
europepmc   +1 more source

Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment. [PDF]

J Am Heart Assoc
Yu L, Xiang B, Ren Y, Li Y, Xie J, Zhou X.   +5 more
europepmc   +1 more source

Exploring the Pleiotropy of PCSK9: A Wide Range of Influences from Lipid Regulation to Extrahepatic Function

Journal of Inflammation Research
Huaru Wang,1 Guodong Tang,2,3 Jianqiang Wu,4 Xuzhen Qin1 1Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China ...
Wang H, Tang G, Wu J, Qin X
doaj  

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. [PDF]

J Lipid Res
Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, Seidah NG, Honarpour N, Lira A, Xue A, Chiruvolu P, Jackson S, Di M, Peach M, Somaratne R, Wasserman SM, Scott R, Stein EA.   +16 more
europepmc   +1 more source

NAT10 promotes gallbladder cancer progression by remodeling cholesterol metabolism via PCSK9 mRNA acetylation. [PDF]

Cell Death Discov
Chen ZY, Wang MY, Ma B, Zhao C, Pan LJ, Wang ZY, Wang YT, Mao PY, Zhao X, Qin DL, Shu YJ, Zhang YJ, Xiang SS, Dong P.   +13 more
europepmc   +1 more source

Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study. [PDF]

Medicine (Baltimore)
Zhang P, Wang H, Lin M, Dai P, Zhong Q, Wang R, Sheng L, He Z, Nan Z.   +8 more
europepmc   +1 more source

Early PCSK9 Inhibitor Use Correlates With Improved Outcomes in Patients With Acute Stroke Receiving Endovascular Therapy. [PDF]

J Am Heart Assoc
Wu T, Zhao X, Xiao M, Deng J, Chen Z, Cheng D, Pan S, Liu X, Wu Y, Huang K.   +9 more
europepmc   +1 more source

Differential expression of GLP1R, PCSK9, and SGLT2 in human aortic versus mitral valve tissues: exploratory findings in calcific aortic valve disease. [PDF]

Front Cardiovasc Med
Cheng SQ, Fu S, Liu NF.
europepmc   +1 more source

Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational Studies. [PDF]

JACC Adv
Blais JE, Zhong W, Li CYV, Kongkaew C, Chan AHY.   +4 more
europepmc   +1 more source

Enzyme-Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors. [PDF]

Chembiochem
Zhang Y, Wang L, Corcilius L, Reji AK, Payne RJ, Hong B, Durek T, Wang CK, Craik DJ.   +8 more
europepmc   +1 more source